Clinical Trial Update: Safety and Efficacy of Vanoxerine for Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm [Phase 2]

View source ↗

Summary

A Phase 2 study of vanoxerine for converting symptomatic atrial fibrillation or atrial flutter to normal sinus rhythm has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter

Drugs mentioned

• Vanoxerine (vanoxerine)

Snippet

Sponsor: Laguna Pharmaceuticals, Inc. | Conditions: Symptomatic Atrial Fibrillation, Atrial Flutter | Phase 2 | Status: COMPLETED | Results posted: 2015-12-22